Key unmet needs in T-cell lymphoma: developing novel therapeutic strategies to improve outcomes

Swaminathan Iyer, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, comments on the need to develop new therapeutics to improve the outcomes of patients with T-cell lymphoma (TCL). This interview took place at the 28th Congress of the European Hematology Association (EHA) 2023 in Frankfurt, Germany.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.